Evaluation of Napabucasin as a direct inhibitor of cancer stem cells in biliary tract cancer

Research output

Research output per year 2019 2019 2019

• 1 Original Article

Research output per year

Research output per year

Search results

• 2019

  The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics.

  Beyreis, M. (First author), Gaisberger, M. (Co-author), Jakab, M. (Co-author), Neureiter, D. (Co-author), Helm, K. (Co-author), Ritter, M. (Co-author), Kiesslich, T. (Co-author) & Mayr, C. R. (Last author), 2019, In: Cancers. 11, 3

  Research output: Contribution to journal › Original Article › peer-review

  19 Citations (Web of Science)